Alcohol consumption, folate intake, hepatocellular carcinoma, and liver disease mortality

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 3, 2013, Pages 415-421

  Persson, E Christina ^a   Schwartz, Lauren M ^a   Park, Yikyung ^b   Trabert, Britton ^a   Hollenbeck, Albert R ^c   Graubard, Barry I ^a   Freedman, Neal D ^b   McGlynn, Katherine A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Nutritional Epidemiology Branch   (United States)

^c AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CANCER INCIDENCE; CANCER REGISTRY; CHRONIC LIVER DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PORTION SIZE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; VITAMIN INTAKE;

AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; DIET; FEMALE; FOLIC ACID; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84876549288     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1169     Document Type: Article

References (40)

1. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485-91.
2. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La VC. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007;46: 827-39. (Pubitemid 46529045)
3. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis 2009;27:80-92.
4. Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011;140: 1182-8.
5. Persson EC, Quraishi SM, Welzel TM, Carreon JD, Gridley G, Graubard BI, et al. Risk of liver cancer among US male veterans with cirrhosis, 1969-1996. Br J Cancer 2012;107:195-200.
6. Davila JA, Morgan RO, Shaib Y,McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004;127:1372-80. (Pubitemid 39457763)
7. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202-19. (Pubitemid 36538699)
8. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126:460-8. (Pubitemid 38182303)
9. Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a population-based case-control study. Hepatology 2011;54:463-71.
10. HassanMM,Hwang LY, Hatten CJ,SwaimM, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergismof alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206-13. (Pubitemid 35253437)
11. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S87-S96. (Pubitemid 39423374)
12. Alcohol drinking.IARC Working Group Lyon, France, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum 1988;44:1-378.
13. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey SG. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 2010;340:c1240.
14. Kuo CS, Lin CY,WuMY, Lu CL, Huang RF. Relationship between folate status and tumour progression in patients with hepatocellular carcinoma. Br J Nutr 2008;100:596-602.
15. Lieber CS. Hepatic, metabolic, and nutritional disorders of alcoholism: from pathogenesis to therapy. Crit Rev Clin Lab Sci 2000;37:551-84. (Pubitemid 32062105)
16. Welzel TM, Katki HA, Sakoda LC, Evans AA, London WT, Chen G, et al. Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort. Cancer Epidemiol Biomarkers Prev 2007;16:1279-82. (Pubitemid 46984971)
17. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health- American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25. (Pubitemid 33140635)
18. Fritz AG. International classification of diseases for oncology ICD-O. 3rd ed. Geneva: World Health Organization; 2000.
19. Michaud DS, Midthune DD, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 2005;32:70-5.
20. Thompson FE,Kipnis V, Midthune D, Freedman LS,Carroll RJ,Subar AF, et al. Performance of a food-frequency questionnaire in the US NIH- AARP (National Institutes of Health-American Association of Retired Persons) Diet and Health Study. Public Health Nutr 2008;11:183-95.
21. Tippett KS, Cypel YS. Design and operation: the continuing survey of food intakes by individuals and diet and health knowledge survey, 1994-96. US Department of Agriculture, Agricultural Research Service; 1997. Report No. 96-1.
22. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27. (Pubitemid 16095831)
23. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980- 2003. Am J Gastroenterol 2010;105:1782-7.
24. Schutze M, Boeing H, Pischon T, Rehm J, Kehoe T, Gmel G, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011;342:d1584.
25. Boffetta P, Hashibe M, La VC, Zatonski W, Rehm J. The burden of cancer attributable to alcohol drinking. Int J Cancer 2006; 119:884-7. (Pubitemid 44051453)
26. Dong C, Yoon YH, Chen CM, Yi HY. Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006. J Stud Alcohol Drugs 2011;72:892-902.
27. Shimazu T, Sasazuki S, Wakai K, Tamakoshi A, Tsuji I, Sugawara Y, et al. Alcohol drinking and primary liver cancer: A pooled analysis of four Japanese cohort studies. Int J Cancer 2012;30:2645-53.
28. Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 2011;103:1686-95.
29. Huang RF, Hsu YC, Lin HL, Yang FL. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 2001;131:33-8. (Pubitemid 32060619)
30. Jackson CD, Weis C, Miller BJ, James SJ. Dietary nucleotides: effects on cell proliferation following partial hepatectomy in rats fed NIH-31, AIN-76A, or folate/methyl-deficient diets. J Nutr 1997;127(5 Suppl): 834S-7S. (Pubitemid 27209451)
31. Biswas A, Senthilkumar SR, Said HM. Effect of chronic alcohol exposure on folate uptake by liver mitochondria. Am J Physiol Cell Physiol 2012;302:C203-C209.
32. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr 2002;132(8 Suppl): 2367S-72S. (Pubitemid 34848109)
33. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, et al. The effect of 677C->T and 1298A->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000;83:593-6. (Pubitemid 30392098)
34. Jin F, Qu LS, Shen XZ. Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Diagn Pathol 2009;4:39.
35. Fabris C, Toniutto P, Falleti E, Fontanini E, Cussigh A, Bitetto D, et al. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Alcohol Clin Exp Res 2009;33:102-7.
36. Donato F, Gelatti U, Limina RM, Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 2006; 25:3756-70. (Pubitemid 43980471)
37. Donato F, Tagger A, Chiesa R, Ribero ML, Tomasoni V, Fasola M, et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study. Hepatology 1997;26:579-84. (Pubitemid 27392347)
38. Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155:323-31. (Pubitemid 34132050)
39. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349:825-32. (Pubitemid 27129209)
40. Lin CC, Liu WH, Wang ZH, Yin MC. Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr 2011;50:499-506.